Scancell Holdings (FRA:SCP) 3-Year Dividend Growth Rate : 0.00% (As of Oct. 2023)

View and export this data going back to 2013. Start your Free Trial

What is Scancell Holdings 3-Year Dividend Growth Rate?

Scancell Holdings's Dividends per Share for the six months ended in Oct. 2023 was €0.00.

The historical rank and industry rank for Scancell Holdings's 3-Year Dividend Growth Rate or its related term are showing as below:

FRA:SCP's 3-Year Dividend Growth Rate is not ranked ^*
in the Biotechnology industry.
Industry Median: 14.15
* Ranked among companies with meaningful 3-Year Dividend Growth Rate only.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

Scancell Holdings's Dividend Payout Ratio for the six months ended in Oct. 2023 was 0.00. As of today, Scancell Holdings's Dividend Yield % is 0.00%.

For more information regarding to dividend, please check our Dividend Page.

Competitive Comparison of Scancell Holdings's 3-Year Dividend Growth Rate

For the Biotechnology subindustry, Scancell Holdings's 3-Year Dividend Growth Rate, along with its competitors' market caps and 3-Year Dividend Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Scancell Holdings's 3-Year Dividend Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Scancell Holdings's 3-Year Dividend Growth Rate distribution charts can be found below:

* The bar in red indicates where Scancell Holdings's 3-Year Dividend Growth Rate falls into.

Scancell Holdings 3-Year Dividend Growth Rate Calculation

This is the average annual rate that a company has been raising its dividends. The growth rate is calculated with expontential compound based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

Scancell Holdings (FRA:SCP) 3-Year Dividend Growth Rate Explanation

1. Dividend Payout Ratio measures the percentage of the company's earnings paid out as dividends.

Scancell Holdings's Dividend Payout Ratio for the quarter that ended in Oct. 2023 is calculated as

Dividend Payout Ratio	=	Dividends per Share (Q: Oct. 2023 )	/	EPS without NRI (Q: Oct. 2023 )
	=	0	/	-0.008
	=	N/A

2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Scancell Holdings 3-Year Dividend Growth Rate Related Terms>

Scancell Holdings (FRA:SCP) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Scancell Holdings PLC (FRA:SCP) » Definitions » 3-Year Dividend Growth Rate

Comparable Companies

Traded in Other Exchanges

SCLP.GB:UK SCLP:UK

Address

Sanders Road, Unit 202, Bellhouse Building, Oxford Science Park, Oxford, GBR, OX4 4GD

Website

https://www.scancell.co.uk

Scancell Holdings PLC is engaged in the discovery and development of novel vaccines for the treatment of cancer. The company is exploiting the unrivalled potential of the immune system to seek out and destroy cancer using two proprietary immuno-oncology platforms: ImmunoBody and Moditope. Its potent innovative DNA-based ImmunoBody therapies generate ultra-high avidity T cell responses that target and eliminate cancerous tumors. Its Moditope platform technology overcomes the immune suppression induced by tumors themselves, allowing activated T cells to seek out and kill tumor cells that would otherwise be hidden from the immune system.

Scancell Holdings (FRA:SCP) Headlines

No Headlines